ECCO 2020 Poster – An evaluation of the impact of IBDoc

BÜHLMANN IBDoc®:

Sugrue, K. et al.  N12: An evaluation of the impact of IBDoc in clinical practice 5 years after introduction.  ECCO 2020, Feb 12 – 15, 2020. Vienna, Austria.

Highlights from this Publication

“This study shows the benefits of using IBDoc® in clinical practice. It is central to facilitating a fast track system for patients which results in better outcomes for patients”

Read Citation

Health Canada Licence: 98903, Device class: 3 

BÜHLMANN IBDoc® is Not Available for Sale in the US.